Improving intravenous-to-oral antibiotic switch in children: a team-based audit and implementation approach

Brendan Joseph McMullan1,2,3, Michelle Mahony4, Lolita Java5

  • 1Department of Immunology and Infectious Diseases, Sydney Children's Hospital Randwick, Sydney, New South Wales, Australia b.mcmullan@unsw.edu.au.

BMJ Open Quality
|March 18, 2021
PubMed

Insights

A quality improvement program successfully increased timely switching from intravenous to oral antibiotics in hospitalized children. This initiative reduced antibiotic overuse and shortened hospital stays, facilitating faster patient discharge.

Area of Science:

  • Pediatric Infectious Diseases
  • Hospital Quality Improvement
  • Antimicrobial Stewardship

Background:

  • Hospitalized children often receive intravenous antibiotics longer than necessary, contributing to overuse and potential complications.
  • Optimizing the switch from intravenous to oral antibiotics can reduce in-hospital antibiotic exposure and length of stay.
  • Timely antibiotic regimen adjustment is crucial for effective pediatric care and resource management.

Purpose of the Study:

  • To implement and evaluate a quality improvement program for timely and safe intravenous-to-oral antibiotic switching in hospitalized children.
  • To assess the impact of a guideline-based intervention, including education, audit, and feedback, on antibiotic switch practices.
  • To determine the effect of the intervention on key clinical outcomes such as length of stay and readmission rates.

Main Methods:

  • A 12-month quality improvement project was conducted in a tertiary pediatric hospital.
  • An evidence-based guideline for intravenous-to-oral antibiotic switch was implemented, supported by team-based education and feedback.
  • Outcomes included the proportion of eligible children switched within 24 hours, time to switch, hospital length of stay, and readmission rates.

Main Results:

  • The percentage of eligible children switched within 24 hours significantly increased from 64% to 82% (p=0.006).
  • Median time to switch decreased from 15 hours 42 minutes to 4 hours 20 minutes (p=0.0006).
  • A significant 14-hour median reduction in hospital length of stay was observed (p=0.008).

Conclusions:

  • The quality improvement approach effectively enhanced the timeliness and safety of intravenous-to-oral antibiotic switching in pediatric patients.
  • The intervention led to reduced hospital length of stay, promoting earlier discharge.
  • This methodology provides a scalable model for improving antibiotic stewardship in pediatric inpatient settings.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
83
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
90
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
90
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs...
190
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.4K
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
106